deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT00442026

Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC

A Multicenter Randomized Phase III Study of the Docetaxel and Gemcitabine Combination Versus Monotherapy With Gemcitabine as First-line Treatment in Elderly Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC)

Sponsor: Hellenic Oncology Research Group

Conditions Non-small-cell Lung Cancer
Interventions Docetaxel Gemcitabine
Updated 6 times since 2017 Last updated: Jun 26, 2012 Started: Dec 31, 2006 Primary completion: May 31, 2010 Completion: May 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Due to poor accrual

Other terminated trials from Hellenic Oncology Research Group

More terminations from Hellenic Oncology Research Group

Other Non-small-cell Lung Cancer trials with similar outcome

Browse all Non-small-cell Lung Cancer trials

This PHASE3 trial investigates Non-small-cell Lung Cancer and is currently terminated or withdrawn. Hellenic Oncology Research Group leads this study, which shows 6 recorded versions since 2006 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 11 months · monthly snapshotTerminated

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hellenic Oncology Research Group
  • University Hospital of Crete
Data source: Hellenic Oncology Research Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations